Agritope Awarded Another Plant Biotechnology Patent.Business Editors, Biotechnology/Agriculture Writers PORTLAND, Ore.--(BUSINESS WIRE)--June 29, 2000 Agritope, Inc. (Nasdaq:AGTO AGTO Association of Golf Tour Operators ) today announced the issuance of a new US patent for its biotechnology program. The patent, number 6,054,635, covers a novel plant gene promoter derived from raspberry fruit. This promoter is a specific sequence of DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. that directs the expression of any gene linked to the promoter. "Promoters are fundamental components of all biotechnology platforms because an effective promoter is necessary to activate genes in a precise manner," said Adolph J. Ferro, president and chief executive officer. "Agritope has a very active promoter discovery program that is critical for our company's ability to achieve improved traits in plant products and that allows us to conduct our research without incurring costs of licensing promoters owned by others." The newly patented promoter, named RE4, can control gene activity in many or all tissues in a given plant. In studies to date, Agritope scientists have determined that RE4 directs gene expression in a number of plants in addition to raspberry. This broad spectrum of plant species includes apple, arabidopsis, garlic, lettuce, melon, onion, pear, tobacco and tomato. RE4 can also be used to control the activity of marker genes, which are important research tools used to confirm the presence of a new gene or trait in a plant. The utility of the RE4 promoter for molecular plant breeding plant breeding, science of altering the genetic pattern of plants in order to increase their value. Increased crop yield is the primary aim of most plant-breeding programs; advantages of the hybrids and new varieties developed include adaptation to new agricultural is greatly enhanced by the fact that it is a naturally occurring plant DNA sequence DNA sequence Genetics The precise order of bases–A,T,G,C–in a segment of DNA, gene, chromosome, or an entire genome. See Base pair, Base sequence analysis, Chromosome, Gene, Genome. . Thus, it can replace commonly used promoters of non-plant origin when creating improved plant varieties. Agritope's patent portfolio now consists of 17 issued US Patents, 12 issued foreign patents as well as applications for an additional 57 patents pending. In addition, its 50% owned joint venture Agrinomics LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control has five patent applications pending. Agritope is an Oregon-based agricultural functional genomics Noun 1. functional genomics - the branch of genomics that determines the biological function of the genes and their products genomics - the branch of genetics that studies organisms in terms of their genomes (their full DNA sequences) and biotechnology company that develops improved plant products and provides technology to the agricultural industry. Its fruit and vegetable division specializes in the development of improved fruit, vegetable and flower varieties. Agrinomics LLC, its 50% owned joint venture with Aventis CropScience (NYSE NYSE See: New York Stock Exchange :AVE), conducts a research, development and commercialization program in the field of plant functional genomics. Vinifera, Inc., its majority owned subsidiary, offers superior grapevine plants to the premium wine industry. Certain statements in this release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Statements that expressly or by implication predict future results, performance or events are forward-looking. The words "believes," "intends," "expects," "anticipates," "estimates," and similar expressions often identify forward looking-statements. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company or industry results to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. With respect to Agritope, these factors include its limited independent operating history; uncertainty of additional funding; loss or impairment of sources of capital; dependence on strategic partners; uncertainties relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc patents and proprietary information; dependence on key personnel; technological change and competition; uncertainties as to consumer acceptance of genetically engineered genetically engineered adjective Recombinant, see there products; changes in laws or regulations; as well as the other factors discussed in Exhibit 99 to the Company's 1999 Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. , which is hereby incorporated by reference. Given these uncertainties, readers are cautioned not to place undue reliance on the forward-looking statements. Agritope does not intend to update any forward-looking statements. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion